Pleural effusion and fibrosis secondary to Sansert administration.
作者信息
Dunn J M, Sloan H
出版信息
Ann Thorac Surg. 1973 Mar;15(3):295-8. doi: 10.1016/s0003-4975(10)65302-7.
PMID:4690824
Abstract
摘要
相似文献
1
Pleural effusion and fibrosis secondary to Sansert administration.
Ann Thorac Surg. 1973 Mar;15(3):295-8. doi: 10.1016/s0003-4975(10)65302-7.
2
Pleural effusion and fibrosis during treatment with methysergide.
Br Med J. 1970 Mar 7;1(5696):605-6. doi: 10.1136/bmj.1.5696.605.
3
Pleural thickening caused by Sansert and Ergotrate in the treatment of migraine.
AJR Am J Roentgenol. 1980 Aug;135(2):375-7. doi: 10.2214/ajr.135.2.375.
4
[Pleurisy and pleural fibrosis developing during treatment with methysergide].
Nord Med. 1968 May 23;79(21):681-4.
5
[Pleuro-pulmonary fibrosis caused by methysergide].
Nouv Presse Med. 1981 Jul 4;10(29):2440-1.
6
Cardiac and pulmonary fibrosis during methysergide therapy for headache.
Trans Am Clin Climatol Assoc. 1967;78:79-92.
7
Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
Respir Med. 1998 Sep;92(9):1172-4. doi: 10.1016/s0954-6111(98)90415-2.
8
[Pleuro-pulmonary fibrosis caused by methysergide].
Sem Hop Ther. 1976 Jan;52(1):9-13.
9
[Letter: Pleuropulmonary fibrosis due to methysergide with circulating immune complexes[].
Nouv Presse Med. 1975 Nov 15;4(39):2809.
10
Pulmonary complications of drug therapy.
Radiology. 1970 Jul;96(1):31-8. doi: 10.1148/96.1.31.
Zotero 插件